About Alnylam Pharma (ALNY)
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The Company is focused on the use of its N-acetylgala... Read more
- USD321.12
- USD321.12
- USD312.96
- USD333.70
- 6.70%
- 2.3B
- 536.50k
- 942.55k
- 43.3B
- 205.87
- 25.20%
Stock News
2 hours ago
Investors in the ‘TACO trade’ should study the other side of the menu, strategists say
MarketWatch
3 hours ago
Valneva Announces Lifting of European Medicines Agency’s Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly
Yahoo
4 hours ago
Nvidia's Jensen Huang sells more than $36 million in stock, catches Warren Buffett in net worth
CNBC
5 hours ago
Trump budget chief Vought ramps up criticism of Powell, vows investigation into Fed renovations
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
